Optimization of Phase-Change Contrast Agents for Targeting MDA-MB-231 Breast Cancer Cells (Q91516516)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30228045 AND SRC:MED&resulttype=core&format=json

23 April 2020

title

Optimization of Phase-Change Contrast Agents for Targeting MDA-MB-231 Breast Cancer Cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30228045 AND SRC:MED&resulttype=core&format=json

23 April 2020

1 reference

4

Paul A Dayton

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30228045 AND SRC:MED&resulttype=core&format=json

23 April 2020

author name string

Kyle P Hadinger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30228045 AND SRC:MED&resulttype=core&format=json

23 April 2020

Joseph P Marshalek

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30228045 AND SRC:MED&resulttype=core&format=json

23 April 2020

Paul S Sheeran

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30228045 AND SRC:MED&resulttype=core&format=json

23 April 2020

Terry O Matsunaga

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30228045 AND SRC:MED&resulttype=core&format=json

23 April 2020

publication date

15 September 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30228045 AND SRC:MED&resulttype=core&format=json

Ultrasound in Medicine and Biology

23 April 2020

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30228045 AND SRC:MED&resulttype=core&format=json

23 April 2020

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30228045 AND SRC:MED&resulttype=core&format=json

23 April 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30228045 AND SRC:MED&resulttype=core&format=json

23 April 2020

page(s)

2728-2738

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30228045 AND SRC:MED&resulttype=core&format=json

Ruthenium polypyridyl complex inhibits growth and metastasis of breast cancer cells by suppressing FAK signaling with enhancement of TRAIL-induced apoptosis

23 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.ULTRASMEDBIO.2018.08.003

Threshold of fragmentation for ultrasonic contrast agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.ULTRASMEDBIO.2018.08.003

A model for reflectivity enhancement due to surface bound submicrometer particles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.ULTRASMEDBIO.2018.08.003

Acoustic droplet vaporization for therapeutic and diagnostic applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.ULTRASMEDBIO.2018.08.003

Pharmacokinetics of perfluorobutane following intravenous bolus injection and continuous infusion of sonazoid in healthy volunteers and in patients with reduced pulmonary diffusing capacity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.ULTRASMEDBIO.2018.08.003

Folate-targeted therapeutic and imaging agents for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.ULTRASMEDBIO.2018.08.003

Dual-targeted and pH-sensitive Doxorubicin Prodrug-Microbubble Complex with Ultrasound for Tumor Treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.ULTRASMEDBIO.2018.08.003

Intracellular delivery and ultrasonic activation of folate receptor-targeted phase-change contrast agents in breast cancer cells in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.ULTRASMEDBIO.2018.08.003

Phase-change nanoparticles using highly volatile perfluorocarbons: toward a platform for extravascular ultrasound imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.ULTRASMEDBIO.2018.08.003

On the thermodynamics and kinetics of superheated fluorocarbon phase-change agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.ULTRASMEDBIO.2018.08.003

Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.ULTRASMEDBIO.2018.08.003

Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.ULTRASMEDBIO.2018.08.003

Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasound

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.ULTRASMEDBIO.2018.08.003

Decafluorobutane as a phase-change contrast agent for low-energy extravascular ultrasonic imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.ULTRASMEDBIO.2018.08.003

Design of ultrasonically-activatable nanoparticles using low boiling point perfluorocarbons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.ULTRASMEDBIO.2018.08.003

Methods of Generating Submicrometer Phase-Shift Perfluorocarbon Droplets for Applications in Medical Ultrasonography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.ULTRASMEDBIO.2018.08.003

Microbubble Compositions, Properties and Biomedical Applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.ULTRASMEDBIO.2018.08.003

Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.ULTRASMEDBIO.2018.08.003

Therapeutic applications of lipid-coated microbubbles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.ULTRASMEDBIO.2018.08.003

MR imaging of ovarian tumors using folate-receptor-targeted contrast agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.ULTRASMEDBIO.2018.08.003

Acoustic and photoacoustic molecular imaging of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.ULTRASMEDBIO.2018.08.003

Folate receptor-targeted liposomes enhanced the antitumor potency of imatinib through the combination of active targeting and molecular targeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.ULTRASMEDBIO.2018.08.003

10.1016/J.ULTRASMEDBIO.2018.08.003

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30228045 AND SRC:MED&resulttype=core&format=json

23 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30228045 AND SRC:MED&resulttype=core&format=json

23 April 2020

PubMed publication ID

30228045

1 reference